Borje Andersson is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 654 publications with 20,009 citations (h-index 75); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304009
Telephone
713-792-6161Registry record last updated 28 May 2019.
Clinical trials
- Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pharmacyclics LLC, An AbbVie CompanyProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1996–1999 per NIH RePORTER. The latest:
- CYCLOPHOSPHAMIDE RESISTANCE IN MYELOID LEUKEMIA
University of Texas Md Anderson Can Ctr
FY1999R01CA067270 - CYCLOPHOSPHAMIDE RESISTANCE IN MYELOID LEUKEMIA
University of Texas Md Anderson Can Ctr
FY1998R01CA067270 - CYCLOPHOSPHAMIDE RESISTANCE IN MYELOID LEUKEMIA
University of Texas Md Anderson Can Ctr
FY1997R01CA067270
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
Journal of Hematology & Oncology
2021 - Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review
Expert Opinion on Drug Metabolism & Toxicology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”